Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.

Xhaard, Alienor;Xhaard, Constance;D'Aveni, Maud;Salvator, Helene;Rubio, Marie-Therese;et.al.
(2021) British Journal of Haematology — Vol. 192, n° 5, p. e121-e124 (2021)

Files

BJH-192-e121.pdf
  • Open Access
  • Adobe PDF
  • 139.34 KB
Download

Details

Authors
  • Xhaard, Alienor
    Author
  • Xhaard, Constance
    Author
  • D'Aveni, Maud
    Author
  • Salvator, Helene
    Author
  • Poire, XavierUCLouvain
    Author
  • Rubio, Marie-Therese
    Author
Show more
Abstract
(en) Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged in China in December 2019 and rapidly spread worldwide. Epidemiological studies in the general population identified older age, diabetes, obesity, hypertension, cardiovascular diseases, chronic lung diseases, end-stage renal and liver diseases, cancer and haematological malignancies, as risk factors for severity and mortality. Allogeneic haematopoietic stem cell transplantation (alloHSCT) recipients were also considered at risk of severe COVID-19, as respiratory viral infections in alloHSCT recipients are associated with significant morbidity and mortality. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Xhaard, A., Xhaard, C., D’Aveni, M., Salvator, H., Chabi, M.-L., Berceanu, A., Coman, T., Beguin, Y., Chalandon, Y., Poire, X., Loschi, M., Paillard, C., Bruno, B., Ceballos, P., Dalle, J.-H., Bilger, K., Bay, J.-O., Robin, M., N’Guyen-Quoc, S., & Rubio, M.-T. (2021). Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study. British Journal of Haematology, 192(5), e121-e124. https://doi.org/10.1111/bjh.17260 (Original work published 2021)